Karyopharm Therapeutics Inc (KPTI) stock news · rev $146.1M
Karyopharm Therapeutics Inc (KPTI) is a biotechnology company listed on US.
This KPTI news page leads with what Karyopharm Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for KPTI yet. We will not pad this page with generic market recap.
Latest reported KPTI revenue for 2025-12-31 was $146.1M. Net income was -$196.0M. Revenue was up 0.6% from 2024-12-31 to 2025-12-31. KPTI currently screens at market cap $205.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the KPTI stock page; for the tape open the quote page.
KPTI stock news FAQ
What are KPTI's latest revenue and net income?
Latest cached Karyopharm Therapeutics Inc (KPTI) revenue for Dec 31, 2025 was $146.1M. Net income was -$196.0M. Statements: https://lician.com/financials/kpti
How did KPTI revenue change from the prior cached period?
Cached Karyopharm Therapeutics Inc (KPTI) revenue was up 0.6% from $145.2M (Dec 31, 2024) to $146.1M (Dec 31, 2025). Statements: https://lician.com/financials/kpti
What is KPTI's market cap?
Karyopharm Therapeutics Inc (KPTI) market cap is $205.6M on the latest cached fundamentals snapshot.
What kind of company is KPTI?
Karyopharm Therapeutics Inc (KPTI) is a biotechnology company listed on US.
Where is KPTI stock news listed?
Cached stock news for Karyopharm Therapeutics Inc (KPTI) is listed at https://lician.com/news/kpti. Filings: https://lician.com/sec/kpti
Not investment advice.